{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-002071","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2025-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.825635+00:00","generated_at":"2026-05-28T06:32:47.158291+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Citius Pharma raises ~$3M in registered direct offering of stock and warrants","bullets":["Offering of 743,496 shares plus warrants for 743,496 shares at combined price of $4.035 per unit.","Warrants exercisable at $4.035/share (8-K) or $3.91/share (press release), expire in 5 years.","Net proceeds ~$2.7M after fees; intended for clinical development and working capital.","H.C. Wainwright placement agent with 7% cash fee, $50k legal, $35k expense, and 52,045 placement agent warrants at $5.0438.","Offering closed January 8, 2025 under effective shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-002071","json":"https://secwatch.observer/filing/0001213900-25-002071.json","markdown":"https://secwatch.observer/filing/0001213900-25-002071.md","text":"https://secwatch.observer/filing/0001213900-25-002071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/0001213900-25-002071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/ea0227130-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T06:32:47.158291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}